Medication-assisted treatment in vulnerable patient populations

Ashlyn Curry is a final-year PharmD candidate at the University of Arkansas for Medical Sciences College of Pharmacy, and Megan Wright is a final-year PharmD candidate at the University of North Carolina at Chapel Hill UNC Eshelman School of Pharmacy. Both are members of the 2021–22 APhA–ASP Policy Standing Committee.

Last year, the APhA–ASP House of Delegates passed Resolution 2021.2, titled “Medication-Assisted Treatment in Vulnerable Patient Populations.” The resolution highlighted the academy’s desire to encourage an increase in access to—and funding for—widespread implementation and utilization of medication-assisted treatment programs for patients suffering from opioid use disorder, specifically in vulnerable patient populations. This was a timely decision given that the most recent data from 2019 estimates that more than 1.4 million people in the United States struggle with a substance use disorder.

Student pharmacists preparing to enter the profession have a duty and responsibility to learn about this topic and prepare to serve patients. Although it may seem intimidating to get involved with an area of pharmacy practice that you are unfamiliar with, we hope that this article will help you feel encouraged to start making impactful changes in your community.

Use destigmatizing language

Medication for opioid use disorder (MOUD) is a treatment approach that combines FDA-approved medications with behavioral therapy in an effort to increase positive outcomes for patients. For a student pharmacist, there are a variety of ways to get involved with assisting vulnerable patients who need MOUD treatment. One of the simplest is to understand the appropriate terminology to use when speaking to them.

De-stigmatizing language is of utmost importance. Opioid use disorder is a chronic condition, and pharmacists shouldn’t approach it any differently than other chronic disease state. For example, avoid phrases like “getting clean” or titles such as “users” or “addicts.” Treating patients with respect and integrity during their MOUD treatment is an impactful way for student pharmacists to make a difference.

The work must continue

There is also a need for advocacy on behalf of both patients and the pharmacy profession. It is important to demonstrate to both state and federal legislators the need for support of vulnerable patient populations regarding access to treatment, and the role that pharmacists can play in their care. Firsthand experience is very helpful for this. Whether it’s from a patient-care event or workplace experience, stories resonate and highlight the current gaps in care that need correction.

The work does not end with the passing of Resolution 2021.2; in so many ways, that is just the beginning. As the academy works to implement this resolution, we hope to use our voices and practice experiences to advocate for patients and to move the profession forward.

For additional information and resources, go to www.pharmacist.com/apha-asp-operation-substance-use-disorders.